Human gut microbiome: hopes, threats and promises

Gut - Tập 67 Số 9 - Trang 1716-1725 - 2018
Patrice D. Cani1,2
1Metabolism and Nutrition Research Group
2Université catholique de Louvain, WELBIO—Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute

Tóm tắt

The microbiome has received increasing attention over the last 15 years. Although gut microbes have been explored for several decades, investigations of the role of microorganisms that reside in the human gut has attracted much attention beyond classical infectious diseases. For example, numerous studies have reported changes in the gut microbiota during not only obesity, diabetes, and liver diseases but also cancer and even neurodegenerative diseases. The human gut microbiota is viewed as a potential source of novel therapeutics. Between 2013 and 2017, the number of publications focusing on the gut microbiota was, remarkably, 12 900, which represents four-fifths of the total number of publications over the last 40 years that investigated this topic. This review discusses recent evidence of the impact of the gut microbiota on metabolic disorders and focus on selected key mechanisms. This review also aims to provide a critical analysis of the current knowledge in this field, identify putative key issues or problems and discuss misinterpretations. The abundance of metagenomic data generated on comparing diseased and healthy subjects can lead to the erroneous claim that a bacterium is causally linked with the protection or the onset of a disease. In fact, environmental factors such as dietary habits, drug treatments, intestinal motility and stool frequency and consistency are all factors that influence the composition of the microbiota and should be considered. The cases of the bacteria Prevotella copri and Akkermansia muciniphila will be discussed as key examples.

Từ khóa


Tài liệu tham khảo

10.1038/ni.2635

Cabinian A , Sinsimer D , Tang M , et al . Gut symbiotic microbes imprint intestinal immune cells with the innate receptor SLAMF4 which contributes to gut immune protection against enteric pathogens. Gut 2017.

Sprockett, 2018, Role of priority effects in the early-life assembly of the gut microbiota, Nat Rev Gastroenterol Hepatol, 15, 197, 10.1038/nrgastro.2017.173

Ximenez, 2017, Development of microbiota in infants and its role in maturation of gut mucosa and immune system, Arch Med Res, 48, 666, 10.1016/j.arcmed.2017.11.007

Milani C , Duranti S , Bottacini F , et al . The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev 2017.

Tilg H , Adolph TE , Gerner RR , et al . The intestinal microbiota in colorectal cancer. Cancer Cell 2018.doi:10.1016/j.ccell.2018.03.004

10.1136/gutjnl-2016-312569

Routy, 2018, The gut microbiota influences anticancer immunosurveillance and general health, Nat Rev Clin Oncol, 15, 382, 10.1038/s41571-018-0006-2

10.1136/gutjnl-2017-313872

Cremonesi E , Governa V , Garzon JFG , et al . Gut microbiota modulate T cell trafficking into human colorectal cancer. Gut 2018:gutjnl-2016-313498.doi:10.1136/gutjnl-2016-313498

10.1136/gutjnl-2017-314205

10.1136/gutjnl-2017-315537

Zuo, 2017, Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome, Gut, 372, gutjnl-2017-313952, 10.1136/gutjnl-2017-313952

Bakhshinejad, 2017, Bacteriophages in the human gut: our fellow travelers throughout life and potential biomarkers of heath or disease, Virus Res, 240, 47, 10.1016/j.virusres.2017.07.013

10.1111/imr.12565

Forde, 2018, Phages of life – the path to pharma, Br J Pharmacol, 175, 412, 10.1111/bph.14106

10.1016/j.tim.2014.02.010

Shkoporov, 2018, Reproducible protocols for metagenomic analysis of human faecal phageomes, Microbiome, 6, 68, 10.1186/s40168-018-0446-z

10.1038/nri3446

10.1038/nri3738

10.1038/nri2710

10.2337/db06-1491

10.1038/ncomms6648

10.1136/gutjnl-2015-310904

Amar, 2008, Energy intake is associated with endotoxemia in apparently healthy men, Am J Clin Nutr, 87, 1219, 10.1093/ajcn/87.5.1219

10.2337/dc10-2197

10.2337/dc10-1676

Monte SV , Caruana JA , Ghanim H , et al . Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2011.

10.1016/j.jnutbio.2009.11.011

Radilla-Vázquez, 2016, Gut microbiota and metabolic endotoxemia in young obese Mexican subjects, Obes Facts, 9, 1, 10.1159/000442479

Gomes, 2017, Metabolic endotoxemia and diabetes mellitus: a systematic review, Metabolism, 68, 133, 10.1016/j.metabol.2016.12.009

10.1038/oby.2011.251

10.1007/s11010-013-1911-4

10.1111/dme.12360

10.1126/science.1179721

10.1053/j.gastro.2014.08.033

10.15252/emmm.201404169

10.1038/ctg.2016.54

10.1152/ajpgi.00048.2015

10.1016/j.cmet.2015.05.020

10.1172/JCI78941

10.1016/j.cmet.2017.03.008

Pallister, 2017, Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome, Sci Rep, 7, 13670, 10.1038/s41598-017-13722-4

10.1038/nrmicro.2017.149

Rastelli, 2018, Gut microbes and health: a focus on the mechanisms linking microbes, obesity, and related disorders, Obesity, 26, 792, 10.1002/oby.22175

10.1016/j.bbr.2014.07.027

Kasselman, 2018, The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity, Atherosclerosis, 271, 203, 10.1016/j.atherosclerosis.2018.02.036

10.1074/jbc.M211609200

Kimura, 2014, The SCFA receptor GPR43 and energy metabolism, Front Endocrinol, 5, 85, 10.3389/fendo.2014.00085

McKenzie, 2017, The nutrition-gut microbiome-physiology axis and allergic diseases, Immunol Rev, 278, 277, 10.1111/imr.12556

Postler TS , Ghosh S . Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab 2017.

Brooks, 2017, Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety, Mol Metab, 6, 48, 10.1016/j.molmet.2016.10.011

10.1016/j.coph.2013.09.008

10.1038/nature08530

Sivaprakasam S , Gurav A , Paschall AV , et al . An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis. Oncogenesis 2016;5:e238.doi:10.1038/oncsis.2016.38

10.1038/bjc.2012.409

10.1126/science.aam9949

10.1126/science.aao2202

10.1016/j.freeradbiomed.2016.09.022

10.1038/nature05414

10.1136/gutjnl-2016-312729

10.1038/nm.3145

Vandeputte, 2017, Quantitative microbiome profiling links gut community variation to microbial load, Nature, 352, 507, 10.1038/nature24460

Schirmer M , Franzosa EA , Lloyd-Price J , et al . Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol 2018.

10.1016/j.cell.2012.10.052

10.1038/nrmicro3451

Suez, 2017, The path towards microbiome-based metabolite treatment, Nat Microbiol, 2, 17075, 10.1038/nmicrobiol.2017.75

Kashyap, 2017, Microbiome at the frontier of personalized medicine, Mayo Clin Proc, 92, 1855, 10.1016/j.mayocp.2017.10.004

10.1016/j.cell.2015.11.001

Noecker, 2016, Getting personal about nutrition, Trends Mol Med, 22, 83, 10.1016/j.molmed.2015.12.010

10.1186/s13073-016-0327-7

10.1038/nature17645

Guilhot, 2018, Methods for culturing anaerobes from human specimen, Future Microbiol, 13, 369, 10.2217/fmb-2017-0170

10.1016/j.cmet.2016.06.013

10.1016/j.cell.2013.12.016

10.1038/nature18646

10.1099/ijs.0.02873-0

Gómez-Gallego, 2016, Akkermansia muciniphila: a novel functional microbe with probiotic properties, Benef Microbes, 7, 571, 10.3920/BM2016.0009

Cani PD , de Vos WM . Next-generation beneficial microbes: the case of Akkermansia muciniphila. Frontiers in microbiology 1765;2017:8.

Mithieux G . Does Akkermansia muciniphila play a role in type 1 diabetes? Gut 2018:gutjnl-2017-315732.doi:10.1136/gutjnl-2017-315732

Romaní-Pérez, 2017, Innovation in microbiome-based strategies for promoting metabolic health, Curr Opin Clin Nutr Metab Care, 20, 1, 10.1097/MCO.0000000000000419

10.2337/db11-0227

10.1073/pnas.1219451110

10.1038/ismej.2014.45

10.3945/jn.115.226688

Song, 2016, Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice, J Gastroenterol Hepatol, 31, 1462, 10.1111/jgh.13278

10.1038/srep16643

Singh, 2017, Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice, Pharmacol Res, 123, 103, 10.1016/j.phrs.2017.06.015

Leal-Díaz, 2016, Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice, Sci Rep, 6, 34242, 10.1038/srep34242

10.1016/j.chom.2014.11.010

10.1136/gutjnl-2014-307142

Greer, 2016, Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism, Nat Commun, 7, 13329, 10.1038/ncomms13329

10.2337/diabetes.

Zhang X , Shen D , Fang Z , et al . Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 2013;8:e71108.doi:10.1371/journal.pone.0071108

10.1186/s40168-016-0222-x

Grander C , Adolph TE , Wieser V , et al . Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut 2017.

10.1186/s13073-016-0271-6

10.1136/gutjnl-2014-308778

Ponziani FR , Bhoori S , Castelli C , et al . Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in non-alcoholic fatty liver disease. Hepatology 2018.doi:10.1002/hep.30036

Khan, 2018, Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients, OMICS, 22, 154, 10.1089/omi.2017.0130

10.1136/gutjnl-2012-303839

10.1038/nature15766

10.2337/dc16-1324

Wang ZS , Horn S; Van , Thomas S; , et al . Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects. Endocrinol Diab Metab 2017:e00009.

10.1038/nm.4236

10.1161/CIRCULATIONAHA.115.019645

Hänninen A , Toivonen R , Pöysti S , et al . Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut 2017:gutjnl-2017-314508.doi:10.1136/gutjnl-2017-314508

10.1161/ATVBAHA.116.307597

Ottman N , Reunanen J , Meijerink M , et al . Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One 2017;12:e0173004.doi:10.1371/journal.pone.0173004

10.1126/science.aad1329

10.1126/science.aan3706

10.1126/science.aar2946

10.1126/science.aao3290

10.1073/pnas.1711233114

10.1073/pnas.1711235114

Heintz-Buschart, 2018, The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder, Mov Disord, 33, 88, 10.1002/mds.27105

Hill-Burns, 2017, Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome, Mov Disord, 32, 739, 10.1002/mds.26942

10.1038/nature11450

10.1038/nature12198

Reveles KR , Ryan CN , Chan L , et al . Proton pump inhibitor use associated with changes in gut microbiota composition. Gut 2017.doi:10.1136/gutjnl-2017-315306

10.1136/gutjnl-2015-310861

10.1136/gutjnl-2015-310376

10.1136/gutjnl-2015-309618

Remely, 2015, Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study, Wien Klin Wochenschr, 127, 394, 10.1007/s00508-015-0755-1

10.1016/j.cell.2014.09.053

Udayappan SD , Kovatcheva-Datchary P , Bakker GJ , et al . Intestinal Ralstonia pickettii augments glucose intolerance in obesity. PLoS One 2017;12:e0181693.doi:10.1371/journal.pone.0181693

10.1038/ismej.2012.153

Knight, 2017, The microbiome and human biology, Annu Rev Genomics Hum Genet, 18, 65, 10.1146/annurev-genom-083115-022438

10.1038/nrgastro.2014.66

Gibson GR , Hutkins R , Sanders ME , et al . Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017;14.doi:10.1038/nrgastro.2017.75

10.1038/nrmicro1152

Wolever, 2016, Personalized nutrition by prediction of glycaemic responses: fact or fantasy?, Eur J Clin Nutr, 70, 411, 10.1038/ejcn.2016.31